Structural basis for pharmacological modulation of the TRPC6 channel.
Institutions | Share |
---|---|
Amgen Cambridge, MA, United States of America (USA) | 0.64 |
Amgen South San Francisco, CA, United States of America (USA) | 0.27 |
Amgen Inc., United States of America (USA) | 0.09 |